Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Fluzone (2006-2007) in Healthy Children
NCT00389857Phase 4Completed
- Sponsor
- Sanofi
- Start
- Oct 2006
- Primary completion
- Sep 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of Fluzone Trivalent in influenza (2 arms), sponsored by Sanofi. Primary endpoint: Geometric Mean Titers of Hemagglutination Inhibition Antibodies. Started Oct 2006; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00389857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00389857.